APA

Stevenson J. P., Rosen M., Sun W., Gallagher M., Haller D. G., Vaughn D., Giantonio B., Zimmer R., Petros W. P., Stratford M., Chaplin D., Young S. L., Schnall M. & O'Dwyer P. J. (20040105). Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Stevenson James P, Rosen Mark, Sun Weijing, Gallagher Maryann, Haller Daniel G, Vaughn David, Giantonio Bruce, Zimmer Ross, Petros William P, Stratford Michael, Chaplin David, Young Scott L, Schnall Mitchell and O'Dwyer Peter J. 20040105. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Stevenson J. P., Rosen M., Sun W., Gallagher M., Haller D. G., Vaughn D., Giantonio B., Zimmer R., Petros W. P., Stratford M., Chaplin D., Young S. L., Schnall M. and O'Dwyer P. J. (20040105). Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Stevenson James P, Rosen Mark, Sun Weijing, Gallagher Maryann, Haller Daniel G, Vaughn David, Giantonio Bruce, Zimmer Ross, Petros William P, Stratford Michael, Chaplin David, Young Scott L, Schnall Mitchell and O'Dwyer Peter J. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20040105.